Indeed, CAFs characteristically have a signature characterised by expression of α-smooth muscle actin, MMP-2, PDGFR, TGFβ and FSP-1, all of which have been reported in LAM lesions. This evidence concerns the gene MMP2 and lymphangioleiomyomatosis.